The Generic Medicines Group is a sector group of Medicines for Europe, representing the generic medicines developers and manufacturers, which provide high-quality cost-competitive medicines to millions of patients in Europe and around the world.

About us

Generic medicines today

The generic medicines industry is at the heart of public health delivery. This industry provides essential medicines that European patients, healthcare professionals and healthcare systems rely on to treat most acute and chronic ailments ranging from cardiovascular, to diabetes and even to cancer. Generic medicines have transformed healthcare in Europe by significantly increasing access to medicine for patients in an era of rising demands for healthcare services and constrained finances. Over the last ten years, generic medicines have increased access to medicines by over 100% in 7 key therapeutic areas without increasing the overall treatment cost. Millions of European patients have benefited from better access to gold standard therapies as a result of this transformation.

Read more

Our 5 Pillars

Generic Medicines are for Patients
Generic Medicines stand for Quality
Generic Medicines are about more Value
Generic Medicines deliver Sustainability
The Generic Medicines industry is committed to Partnership

Read more

What's new

EU Semester Country Specific Recommendations: Improve patient access to medicine and ensure healthcare sustainability

Read more



View all

Did you know?

Bioequivalence is the key factor in creating a generic medicine.


EGA Regulatory and Scientific Affairs Conferenc
EGA Regulatory and Scientific Affairs Conference
28 January 2016
20160127 EGA Pharmacovigilance Conference
20160128 EGA Regulatory and Scientific Affairs Conference
27 January 2016
Launch of the "Regulatory Efficiency Report / 28 September 2015
Launch of the Regulatory Efficiency Report
28 September 2015

View all